Tag: pharmaceuticals

  • Companies, University Team-Up on Drug Side Effects Model

    Researchers at University of California in San Francisco, with colleagues from San Francisco start-up SeaChange Pharmaceuticals and the drug company Novartis, have devised a computer model that predicts adverse reactions to drug compounds, based on the chemistry of the drugs and known molecular causes of side effects. The team’s findings appear online in the journal…

  • Trial Shows Long-Term Benefit of Multiple Sclerosis Drug

    The drug company Novartis today released results of a clinical trial that shows patients with multiple sclerosis taking its drug fingolimod — marketed under the name Gilenya — had fewer relapses and lower brain volume loss, including among patients who switched from a competing drug. The findings are expected to be delivered today at a…

  • Novartis, Foundation Medicine to Partner on Genome Analysis

    The pharmaceutical company Novartis has agreed to use the genomic analysis services of Foundation Medicine in Cambridge, Massachusetts in Novartis’s clinical trials of cancer drugs. The agreement expands an 18-month pilot program between the two companies. Financial terms of the agreement were not disclosed. Foundation Medicine conducts a detailed genomic analysis of tumors to help…

  • Grant to Fund Drug Reformulation for HIV Therapy

    A $1.1 million grant from the National Research Council of Canada will fund research and development at University of British Columbia and iCo Therapeutics Inc. in Vancouver, B.C. to reformulate an existing drug into a therapy to fight HIV infection. The company iCo Therapeutics specializes in redosing or reformulating current drugs into new or expanded…

  • Bristol-Myers Squibb Sponsoring Cancer Research Network

    Bristol-Myers Squibb Co., a pharmaceutical company in Princeton, New Jersey, has a new collaboration with academic researchers that aims to better understand the science of immuno-oncology, the harnessing of the body’s immune system to fight cancer. The network includes researchers from 10 universities and research institutes in the U.S. and Europe. The company says its…

  • Ensemble Therapeutics, Genentech Partner on Drug Discovery

    Ensemble Therapeutics, a biotechnology company in Cambridge, Massachusetts, and Genentech, a subsidiary of the global pharmaceutical company Roche in South San Francisco, California have agreed to collaborate on the development of new drug candidates based on Ensemble’s technology. The financial value of the deal was not disclosed. Ensemble says it has developed a drug discovery…

  • New Standards Released for Drug Impurity Limits, Methods

    U.S. Pharmacopeial Convention (USP) in Rockville, Maryland has published two new standards governing elemental impurities in medications. USP says conformance to the standards will be required starting 1 May 2014. Elemental impurities include catalysts and environmental contaminants such as lead or mercury that may be present in drugs. According to USP, elemental impurities can occur…

  • Superbug Genetic Code Cracked, Resistance Factor Identified

    Researchers at Massachusetts Eye and Ear Infirmary in Boston, with colleagues in the U.S. and U.K., have sequenced the genomes of the 12 available strains of Staphylococcus aureus bacteria resistant to the drug vancomycin, and determined the piece of the genome that makes the strains resistant. The team published its findings yesterday in the online…

  • Lundbeck, Foundation to Partner on Huntington’s Research

    The U.S. subsidiary of the pharmaceutical company Lundbeck A/S and the CHDI Foundation in Los Angeles will collaborate on research for a targeted therapy for Huntington’s Disease. Financial terms of the agreement were not disclosed. Huntington’s disease is an inherited disease that causes the progressive degeneration of nerve cells in the brain, affecting a person’s…

  • Students Design Pill Dispenser for Visually Impaired

    Two undergraduate students of design at University of Cincinnati in Ohio have designed and built a prototype of a prescription-medicine pill bottle that better serves the needs of the blind and visually impaired. Alex Broerman and Ashley Ma will display their device, for which a provisional patent has been filed, at the DAAPworks 2012 show,…